June quarterly report, estimated cash outflow for current quarter was $16m!Cash on hand on 30/06/13- $1.4mBridge loan -$5m (convert to shares?)Right issue - $14mCash won't last long, might need raise more soon or receivership?Might 5-6c
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%